The transition from pediatric to adult care for patients with Lennox-Gastaut syndrome (LGS) is often hindered by fragmented planning and a lack of personalized support. As young adult patients move from home-based care to group homes, assisted living, or long-term …
Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the heavy disease burden and …
A major hurdle in managing type 2 diabetes (T2D) is a widespread gap in clinician awareness around the powerful, far-reaching benefits of GLP-1 receptor agonists (GLP-1 RAs). These innovative therapies help reduce the burden of cardiovascular, kidney, and metabolic (CKM) …
Clinicians face considerable hurdles when diagnosing and managing narcolepsy and idiopathic hypersomnia (IH), largely due to overlapping symptoms, insufficient formal training in sleep medicine, and limited recognition of associated psychiatric and cardiometabolic comorbidities. Compounding the challenge, some therapeutic agents—most notably …
Suboptimal health care and poor health care outcomes for individuals with intellectual and developmental disabilities (IDDs) often stem from health care professionals (HCPs) lacking necessary skills to treat these individuals. It is crucial that HCPs receive education on how to …
Transthyretin amyloidosis (ATTR), including hereditary variants such as ATTRv-CM and ATTRv-PN, remains underdiagnosed despite increased awareness and treatment advances. Many patients experience significant diagnostic delays, often seeing multiple clinicians before receiving a correct diagnosis, which can limit treatment efficacy and …
Idiopathic hypersomnia (IH) and narcolepsy diagnoses share similar symptoms and comorbidities, including cardiovascular (CV), cardiometabolic (CM), neurologic, and psychiatric conditions. Healthcare professionals (HCPs) with patients who have IH or narcolepsy and one or more of these comorbidities need to recognize …
The CMS Health Equity Index is a game-changing tool from the Centers for Medicare & Medicaid Services that tracks how well Medicare Advantage and Part D plans support members with social risk factors. It spotlights performance for individuals facing challenges …
